Daily risedronate prevents bone loss in osteopenic, postmenopausal women:: A 2-year multicenter trial in europe

被引：0
|
作者：
Valmaki, M. [1 ]
Heikkinen, J. [2 ]
Munoz-Torres, M. [3 ]
Mulder, H. [4 ]
Ofjord, E. S. [5 ]
Toss, G. [6 ]
机构：
[1] Univ Helsinki, Cent Hosp, Div Endocrinol, FIN-00014 Helsinki, Finland
[2] Deaconess Inst Oulu, Osteoporosis Clin, Oulu, Finland
[3] Hosp Clin San Cecilio, Granada, Spain
[4] Osteosupport, Rotterdam, Netherlands
[5] Linkoping Univ Hosp, Dept Endocrinol, S-58185 Linkoping, Sweden
[6] Ctr Clin Studies AS, Paradis, Norway
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [31] Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study
    Izumi, K.
    Mizokami, A.
    Sugimoto, K.
    Narimoto, K.
    Kitagawa, Y.
    Koh, E.
    Namiki, M.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (03) : 238 - 242
  • [32] Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study
    K Izumi
    A Mizokami
    K Sugimoto
    K Narimoto
    Y Kitagawa
    E Koh
    M Namiki
    [J]. Prostate Cancer and Prostatic Diseases, 2011, 14 : 238 - 242
  • [33] EFFECT OF CALCIUM SUPPLEMENTATION ON BONE MASS AND CALCIUM METABOLISM IN ADOLESCENTS, LACTATING AND POSTMENOPAUSAL WOMEN: A 2-YEAR RANDOMIZED TRIAL
    Chen, Y.
    Zhang, Z.
    Ma, X.
    Wang, R.
    Li, J.
    Zhong, W.
    Zhang, C.
    Huang, Z.
    Yang, X.
    Su, Y.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1213 - 1213
  • [34] A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
    McClung, Michael R.
    Benhamou, Claude-Laurent
    Man, Zulema
    Tlustochowicz, Witold
    Zanchetta, Jose R.
    Eusebio, Rachelle
    Balske, Ana M.
    Matzkin, Ellen
    Olszynski, Wojciech P.
    Recker, Robert
    Delmas, Pierre D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (01) : 59 - 67
  • [35] Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years
    S. Adami
    L. Bufalino
    R. Cervetti
    C. Di Marco
    O. Di Munno
    L. Fantasia
    G. C. Isaia
    U. Serni
    L. Vecchiet
    M. Passeri
    [J]. Osteoporosis International, 1997, 7 : 119 - 125
  • [36] Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years
    Adami, S
    Bufalino, L
    Cervetti, R
    DiMarco, C
    DiMunno, O
    Fantasia, L
    Isaia, GC
    Serni, U
    Vecchiet, L
    Passeri, M
    Castiglione, GN
    Gardini, F
    Letizia, G
    Occhipinti, L
    Pardini, N
    Agamennone, M
    Sciolla, A
    Matucci, A
    Riboldi, R
    Costi, D
    DallAglio, E
    Pedrazzoni, M
    [J]. OSTEOPOROSIS INTERNATIONAL, 1997, 7 (02) : 119 - 125
  • [37] A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
    Michael R. McClung
    Claude-Laurent Benhamou
    Zulema Man
    Witold Tlustochowicz
    Jose R. Zanchetta
    Rachelle Eusebio
    Ana M. Balske
    Ellen Matzkin
    Wojciech P. Olszynski
    Robert Recker
    Pierre D. Delmas
    [J]. Calcified Tissue International, 2013, 92 : 59 - 67
  • [38] ALENDRONATE PREVENTS BONE LOSS AT THE SPINE AND HIP IN RECENTLY POSTMENOPAUSAL WOMEN
    EISMAN, JA
    CHRISTIANSEN, C
    MCCLUNG, M
    GILCHRIST, N
    LUCKEY, M
    HALE, E
    REDA, C
    DAIFOTIS, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S176 - S176
  • [39] Effect of microdose transdermal 17β-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial
    Schaefers, Matthias
    Muysers, Christoph
    Alexandersen, Peter
    Christiansen, Claus
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (03): : 559 - 565
  • [40] Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial
    Anastasilakis, Athanasios D.
    Papapoulos, Socrates E.
    Polyzos, Stergios A.
    Appelman-Dijkstra, Natasha M.
    Makras, Polyzois
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (12) : 2220 - 2228
12345